Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Trump says Canada's Bombardier must build jets in US or lose market access
- Qualcomm to issue warrant to Amazon for up to 25M shares
- Wall St slips as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Bausch Health Companies (BHC) PT Lowered to $25 at BMO Capital
February 21, 2019 9:35 AM ESTBMO Capital analyst Gary Nachman lowered the price target on Bausch Health Companies (NYSE: BHC) to $25.00 (from $26.00) while maintaining a Market Perform rating.
Nachman notes BHC delivered relatively in-line 4Q and 2019 guidance overall roughly in-line with expectations, although bottom-end of revenue range... More
Bausch Health Co. Inc. (BHC) Q4 Revenue Tops Views, Guidance Misses at Mid-Point
February 20, 2019 7:05 AM ESTBausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of ($0.98), may not compare to the analyst estimate of $0.84. Revenue for the quarter came in at $2.12 billion versus the consensus estimate of $2.08 billion.
GUIDANCE:
Bausch Health Co. Inc. sees FY2019 revenue... More
